Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 and up

Effect of Tranexamic Acid on Bleeding in Cardiac Surgery

Official title: The Dose Effect of Activated Clotting Time and Tranexamic Acid on Bleeding in Adult Cardiac Surgery

Run by Taichung Veterans General Hospital · NCT06109155 · Data updated 2026-11-12

This study is testing how different doses of tranexamic acid can help reduce bleeding and the need for blood transfusions in adults having heart surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorTaichung Veterans General Hospital
Academic / other
Locations2 sites (Taichung and 1 other locations)
StatusRecruiting
StartedFebruary 8, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 21, 2024
Trial IDNCT06109155 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults scheduled for cardiac surgery requiring cardiopulmonary bypass.

Probably not a fit

Patients who are pregnant, undergoing emergency procedures, or have severe comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of different doses of tranexamic acid and activated clotting time (ACT) levels on bleeding and blood transfusion requirements in adult patients undergoing cardiac surgery. Participants will be divided into four groups based on their tranexamic acid dosage and ACT levels during surgery. The primary outcome measured will be the volume of postoperative bleeding within 24 hours. The study aims to enhance understanding of pharmacological management during cardiac procedures.

Why it matters

Potential benefit: If successful, this study could lead to reduced bleeding and blood transfusion needs in cardiac surgery patients.

How similar studies have gone: Previous studies have shown promising results with tranexamic acid in reducing bleeding in surgical settings, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult, cardiac surgery with cardiopulmonary bypass

Exclusion Criteria:

* pregnant
* emergency procedure
* immune compromised
* aortic surgery
* end-stage renal disease
* liver disease
* critical status
* incomplete clinical data

Where it's running

  • Taichung Veterans General Hospital
    Taichung, Taiwan
    Recruiting
  • Taichung Veterans General hospital
    Taichung, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.